Hepatitis Viral Load Testing

Hepatitis Viral Load Test in Kathmandu — HBV DNA and HCV RNA Quantitative PCR — Treatment Monitoring — Suppression and Cure

Hepatitis viral load testing measures HBV DNA or HCV RNA in blood to quantify viral replication, guide treatment decisions, monitor therapy response and confirm cure. Available at Thamel Clinic in Kathmandu with confidential clinical review.

Medically Reviewed Content

Reviewed by: Thamel Clinic Clinical Team (MBBS, MD)

Last medical review: November 8, 2026

Next scheduled review: May 8, 2027

This content follows evidence-based medical guidelines and is regularly updated to reflect current medical practices.

When to Seek Prompt Care

  • If you have hepatitis B or C and develop yellowing of skin or eyes, severe abdominal pain, confusion or vomiting blood — seek urgent medical care.
  • If you are on hepatitis B treatment and miss doses or want to stop — contact your clinician first; stopping suddenly can cause dangerous viral rebound.
  • If you have hepatitis C and completed treatment, the 12-week SVR test is essential — do not skip it.
  • If you have hepatitis and are pregnant or planning pregnancy, contact your clinician — management differs and transmission risk to the baby needs assessment.

Hepatitis Viral Load Testing in Nepal

  • High hepatitis burden — Nepal has significant hepatitis B and C prevalence, particularly in certain regions and populations; viral load testing is essential for managing chronic infection.
  • DAA access for hepatitis C — direct-acting antiviral drugs that cure hepatitis C are increasingly available in Nepal; viral load monitoring confirms cure (SVR12).
  • HBV treatment complexity — hepatitis B treatment decisions depend on viral load, ALT levels and liver staging; monitoring requires regular viral load testing.
  • NPR costs — viral load testing typically costs Rs. 3,000–8,000 depending on the assay; monitoring adds recurring costs that patients should plan for.
  • MOHP programs — Nepal's Ministry of Health supports hepatitis screening and treatment programs; viral load testing is part of the national hepatitis response.
  • Laboratory capacity — quantitative PCR for HBV DNA and HCV RNA is available at Thamel Clinic and major Kathmandu laboratories.

Hepatitis Viral Load Testing — Overview

Hepatitis B and hepatitis C are viral infections of the liver that can become chronic and cause cirrhosis, liver failure and liver cancer if untreated. While blood tests like HBsAg and anti-HCV tell you whether you are infected, viral load testing tells you how much virus is in your blood — a number measured in international units per milliliter (IU/mL) that guides every treatment decision.

For hepatitis B, the viral load test measures HBV DNA — the genetic material of the hepatitis B virus. High HBV DNA levels indicate active viral replication and are associated with liver damage and cancer risk. For hepatitis C, the viral load test measures HCV RNA — the presence of which confirms active infection (unlike antibody tests which can remain positive after cure).

Viral load testing serves three purposes: diagnosis (confirming active infection), treatment decisions (determining who needs treatment and when), and monitoring (tracking response to therapy). For hepatitis C, the goal is a sustained virological response — HCV RNA undetectable 12 weeks after treatment ends — which means cure. For hepatitis B, the goal is viral suppression to protect the liver long-term.

At Thamel Clinic, viral load testing is performed by quantitative PCR — the most accurate method for measuring viral quantity. Results are interpreted by clinicians who understand the nuances: what a high or low viral load means for your specific situation, how it changes over time, and what treatment options are appropriate. This page explains the complete picture.

What Is Hepatitis Viral Load?

Viral load is the amount of virus in your blood, measured in international units per milliliter (IU/mL). For hepatitis B, the test measures HBV DNA — copies of the viral genetic material. For hepatitis C, it measures HCV RNA — the viral genetic material that indicates active infection.

Viral load is different from antibody tests. Antibody tests (like HBsAg for hepatitis B or anti-HCV for hepatitis C) tell you whether you have been exposed to the virus. Viral load tells you whether the virus is actively replicating and how much of it is present — which determines disease activity, treatment need and treatment response.

Viral load results are reported as numbers: undetectable (below the test's lower limit, typically <10 or <15 IU/mL), low (below ~2,000 IU/mL for HBV or ~800,000 IU/mL for HCV), or high (above these thresholds). The meaning depends on which virus you have and your clinical situation.

  • Viral load measures the amount of virus in blood — IU/mL.
  • HBV DNA for hepatitis B; HCV RNA for hepatitis C.
  • Antibody tests show exposure; viral load shows active replication.
  • Undetectable means below the assay's lower limit — context matters.
  • Viral load guides treatment decisions and monitors response.

HBV DNA

Measures hepatitis B virus genetic material — high levels indicate active replication and liver damage risk.

HCV RNA

Measures hepatitis C virus genetic material — presence confirms active infection; undetectable after treatment means cure.

Beyond Antibodies

Antibody tests show exposure; viral load shows whether the virus is actively replicating — different questions, different tests.

IU/mL Units

Results are reported in international units per milliliter — standardized for comparing results over time.

HBV DNA Testing for Hepatitis B

HBV DNA testing measures the amount of hepatitis B virus genetic material in blood. It is used in three ways: to confirm active infection in patients who test positive for HBsAg, to determine whether treatment is needed, and to monitor treatment response over time.

For hepatitis B, treatment decisions depend on multiple factors: HBV DNA level, ALT (liver enzyme) levels, hepatitis B e-antigen status, liver fibrosis stage and patient factors like age and family history. A high HBV DNA (>20,000 IU/mL in HBeAg-positive or >2,000 IU/mL in HBeAg-negative patients) with elevated ALT generally indicates treatment need.

During treatment, HBV DNA should decline progressively. The goal is viral suppression — reducing HBV DNA to undetectable or very low levels — which protects the liver from further damage and reduces cancer risk. Suppression is not the same as cure: the virus can reactivate if treatment stops, so most patients need long-term therapy.

  • HBV DNA confirms active infection in HBsAg-positive patients.
  • Treatment decisions depend on HBV DNA, ALT, e-antigen status and liver stage.
  • High viral load with elevated ALT generally indicates treatment need.
  • Goal of treatment is viral suppression — not cure.
  • Most patients need long-term therapy — stopping can cause reactivation.

When Treatment Is Needed

High HBV DNA plus elevated ALT indicates active liver damage — treatment reduces viral load and protects the liver.

Suppression, Not Cure

HBV treatment suppresses the virus but does not eliminate it — most patients need long-term therapy.

Monitoring Response

HBV DNA should decline during treatment — regular viral load testing confirms the medication is working.

Reactivation Risk

Stopping treatment can cause viral rebound — never stop HBV medication without medical supervision.

HCV RNA Testing for Hepatitis C

HCV RNA testing serves two critical purposes for hepatitis C. First, it confirms active infection — a positive anti-HCV antibody test only shows exposure, while detectable HCV RNA proves the virus is actively replicating. Second, it monitors treatment response and confirms cure.

The treatment goal for hepatitis C is a sustained virological response (SVR) — HCV RNA undetectable 12 weeks after completing treatment (SVR12). This is considered cure: the virus is eliminated from the body, liver damage stops progressing, and the risk of cirrhosis and cancer declines dramatically.

Modern hepatitis C treatment uses direct-acting antivirals (DAAs) — pills taken for 8–12 weeks that cure over 95% of patients. HCV RNA testing before treatment establishes baseline viral load, during treatment may be checked to confirm response, and at 12 weeks post-treatment confirms SVR — the cure.

  • HCV RNA confirms active infection — antibody tests only show exposure.
  • SVR12 (undetectable HCV RNA 12 weeks post-treatment) = cure.
  • DAAs cure over 95% of patients in 8–12 weeks.
  • Baseline, on-treatment and post-treatment RNA tests guide management.
  • Cure dramatically reduces cirrhosis and cancer risk.

Confirming Active Infection

Anti-HCV antibody shows exposure; HCV RNA proves active replication — both are needed for diagnosis.

SVR = Cure

Undetectable HCV RNA 12 weeks after treatment means the virus is eliminated — considered cure.

DAA Treatment

Direct-acting antivirals cure over 95% of patients in 8–12 weeks — a revolution in hepatitis C care.

Monitoring Timeline

Baseline RNA before treatment, response checks during, SVR12 test 12 weeks after — confirms cure.

When Viral Load Testing Is Needed

Viral load testing is needed at specific points in hepatitis management. For newly diagnosed patients, it establishes the baseline — how much virus is present before treatment. This baseline helps determine treatment urgency and provides a reference point for measuring response.

For patients already on treatment, viral load is monitored periodically — typically every 3–6 months for hepatitis B and at specific timepoints for hepatitis C (end of treatment and 12 weeks post-treatment for SVR). The frequency depends on the virus, treatment type and how stable the patient is.

Viral load testing is also needed when treatment decisions change: if a hepatitis B patient's ALT rises or symptoms develop, viral load helps determine whether treatment intensification is needed. For hepatitis C patients who fail DAA therapy (rare), viral load and resistance testing guide second-line options.

  • Baseline viral load at diagnosis — establishes starting point.
  • Every 3–6 months for hepatitis B patients on treatment.
  • End of treatment and 12 weeks post-treatment for hepatitis C SVR.
  • When ALT rises or symptoms change — guides treatment adjustment.
  • For treatment failure — guides second-line therapy decisions.

At Diagnosis

Baseline viral load establishes how much virus is present — guides treatment urgency and provides reference for response.

During Treatment

Regular monitoring every 3–6 months confirms the medication is working and viral load is declining.

Confirming Cure

Hepatitis C patients need HCV RNA at end of treatment and 12 weeks later to confirm SVR — cure.

When Things Change

Rising ALT, new symptoms or treatment concerns trigger viral load testing to guide decisions.

Interpreting Your Viral Load Results

Viral load results are not interpreted in isolation — they must be read in clinical context. A high HBV DNA in a patient with normal ALT and no liver damage may not need immediate treatment; the same high viral load with elevated ALT and fibrosis does. Similarly, a low HCV RNA does not mean no treatment is needed — hepatitis C treatment is recommended regardless of baseline viral load.

Trends matter more than single values. A declining HBV DNA over time shows treatment is working. A stable low-level HCV RNA during treatment may indicate response, while rising levels suggest treatment failure. Comparing results over time gives the clinical picture that a single number cannot.

Undetectable does not always mean cured — for hepatitis B, it means suppressed (virus still present but not replicating actively); for hepatitis C post-treatment, it means cured. Your clinician explains which applies to your situation and what it means for your long-term health and monitoring needs.

  • Results interpreted in clinical context — not in isolation.
  • Trends over time matter more than single values.
  • HBV undetectable = suppressed; HCV undetectable post-treatment = cured.
  • High viral load alone does not always mean immediate treatment needed.
  • Your clinician explains what your specific result means for you.

Context Is Everything

A high HBV DNA with normal ALT may not need treatment; the same level with elevated ALT and fibrosis does.

Trends Over Time

Declining viral load shows treatment working; rising levels suggest problems — compare results over time.

Suppressed vs Cured

HBV undetectable means suppressed (virus dormant); HCV undetectable after treatment means cured (virus gone).

Not Just a Number

Your clinician interprets viral load alongside ALT, liver staging and symptoms — not as an isolated value.

Viral Load Testing Costs and Monitoring Plans

Viral load testing costs vary by assay type and laboratory. Quantitative PCR for HBV DNA or HCV RNA typically costs Rs. 3,000–8,000 in Kathmandu, depending on whether the test is done at Thamel Clinic or a larger reference laboratory. Turnaround time is usually 1–3 days.

Monitoring adds recurring costs: hepatitis B patients on treatment typically need viral load every 3–6 months indefinitely, while hepatitis C patients need fewer tests (baseline, end of treatment, SVR12). Patients should discuss monitoring schedules and costs with their clinician to plan appropriately.

For patients concerned about cost, some monitoring can be done at government facilities at reduced or no cost through MOHP hepatitis programs. Thamel Clinic provides transparent pricing and can coordinate with government programs where available — discuss options at your consultation.

  • Quantitative PCR viral load: Rs. 3,000–8,000 depending on assay and laboratory.
  • Turnaround time typically 1–3 days.
  • Hepatitis B monitoring every 3–6 months — ongoing cost.
  • Hepatitis C needs fewer tests — baseline, end of treatment, SVR12.
  • Government facilities may offer reduced-cost monitoring through MOHP programs.

Transparent Pricing

Viral load testing costs Rs. 3,000–8,000 — exact price confirmed before testing with no hidden fees.

Monitoring Plans

Your clinician designs a monitoring schedule based on your virus, treatment and stability — costs discussed upfront.

Government Options

MOHP hepatitis programs may offer reduced-cost or free viral load monitoring — ask about eligibility.

Value of Monitoring

Regular viral load testing ensures treatment is working and catches problems early — an investment in long-term liver health.

Hepatitis Viral Load Testing — Services and Pricing

ServiceWhat It IncludesCost (NPR)
Specialist consultationAssessment of hepatitis status, treatment history and viral load interpretationRs. 450
HBV DNA quantitative PCRMeasures hepatitis B virus genetic material — guides treatment and monitors responseRs. 4,000–8,000
HCV RNA quantitative PCRMeasures hepatitis C virus genetic material — confirms active infection and cureRs. 3,500–7,000
HCV RNA qualitativeDetects presence/absence of HCV RNA — useful for confirming cureRs. 2,500–5,000
Baseline viral load panelHBV DNA or HCV RNA plus liver function tests for treatment planningRs. 5,000–10,000
Monitoring viral loadPeriodic viral load testing during treatment — frequency individualizedRs. 3,000–8,000 per test
SVR12 confirmationHCV RNA 12 weeks post-treatment to confirm cureRs. 3,500–7,000
Liver function panelALT, AST, bilirubin and other markers of liver healthRs. 1,500–3,000

Prices in NPR and confirmed before testing. Monitoring schedules are individualized based on virus type and treatment.

Why Patients Choose Thamel Clinic for Viral Load Testing

  • Quantitative PCR accuracy — the most sensitive and specific method for measuring viral load.
  • Expert interpretation — clinicians explain what your viral load means in context, not just report a number.
  • Both viruses covered — HBV DNA and HCV RNA testing with correct clinical correlation.
  • Monitoring coordination — schedules designed for your virus, treatment and stability.
  • Treatment linkage — positive results connected to appropriate hepatitis treatment services.
  • Confidential care — private rooms, coded registration and results released only to you.
  • Transparent pricing — clear NPR costs for testing and monitoring before services begin.

Relevant Specialist Expertise

These clinicians provide care within their scope of practice at our clinic.

Portrait of Dr. Sushil Sitaula, Consultant in Internal Medicine

Dr. Sushil Sitaula

Consultant in Internal Medicine

MBBS
MD — Internal Medicine

Nepal Medical Council Registration No. 6973

Dr. Sushil Sitaula is a Consultant in Internal Medicine with a special interest in sexual health. He holds an MBBS and an MD in Internal Medicine and is registered with the Nepal Medical Council (Registration No. 6973).

Key Expertise

General Internal MedicineSexual HealthSexual HealthGeneral Internal Medicine

Frequently Asked Questions

What is hepatitis viral load?

Viral load is the amount of virus in your blood, measured in IU/mL. For hepatitis B it measures HBV DNA; for hepatitis C it measures HCV RNA. It shows whether the virus is actively replicating — different from antibody tests which only show exposure.

What is the difference between HBV DNA and HCV RNA?

HBV DNA measures hepatitis B virus genetic material — used to guide treatment and monitor suppression. HCV RNA measures hepatitis C virus genetic material — confirms active infection and cure (undetectable 12 weeks post-treatment = SVR = cure).

How often do I need viral load testing?

Hepatitis B patients on treatment typically need viral load every 3–6 months. Hepatitis C patients need baseline, end-of-treatment and SVR12 tests. Frequency depends on your virus, treatment and stability — your clinician designs your schedule.

What does an undetectable viral load mean?

For hepatitis B, undetectable means suppressed — virus is controlled but not eliminated; treatment usually continues long-term. For hepatitis C post-treatment, undetectable means cured — the virus is gone. Your clinician explains which applies to you.

How much does viral load testing cost in Kathmandu?

Quantitative PCR viral load testing typically costs Rs. 3,000–8,000 depending on the assay and laboratory. Monitoring adds recurring costs — discuss schedules and options with your clinician. Government facilities may offer reduced-cost testing.

Can viral load testing be done at home?

No — viral load requires quantitative PCR in a laboratory. Home sample collection is available for the blood draw, but the test itself must be performed in a laboratory. Thamel Clinic coordinates collection and testing.

What if my viral load is high?

A high viral load indicates active viral replication. For hepatitis B, it may indicate treatment need depending on ALT and liver stage. For hepatitis C, treatment is recommended regardless of viral load — DAAs cure over 95% of patients. Your clinician explains what your result means.

Is viral load testing confidential?

Yes. Testing at Thamel Clinic is completely confidential — private rooms, coded registration, and results released only to you through your chosen channel. No information is shared with third parties without consent.

What happens if hepatitis C treatment fails?

DAA cure rates exceed 95%, but rare treatment failures occur. Viral load and resistance testing guide second-line therapy options. Your clinician discusses alternatives if first-line treatment does not achieve SVR.

Do I need viral load testing if I feel healthy?

Yes — hepatitis can cause liver damage silently for years before symptoms appear. Viral load monitoring catches problems early and confirms treatment is working, even when you feel completely well.

Still have questions? Contact us or book an appointment for personalized guidance.

Related Services & Guides

Related Health Guides

Medical Review & Sources

Medically reviewed by: Thamel Clinic Clinical Team (MBBS, MD)

Role: Hepatology and infectious disease clinical reviewers, Thamel Clinic, Kathmandu

Last reviewed: 2026-11-08

Reviewed against current WHO, CDC and AASLD/EASL guidance. This is general medical information; a registered clinician must assess each patient before treatment.

View clinic team and credentials

References

  1. Hepatitis B — NHS — NHS, 2025
  2. Hepatitis C — NHS — NHS, 2025
  3. Hepatitis — WHO Fact Sheet — World Health Organization, 2024

Medical information is general guidance only and does not replace an individual consultation. Treatment decisions are made after clinical assessment, including allergy and pregnancy review.

Medical Disclaimer

Important information about using this medical website

Educational Purpose Only

The information provided on this website, including all text, graphics, images, and other material, is for informational and educational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment.

No Doctor-Patient Relationship

Use of this website does not create a doctor-patient relationship. The information provided is not tailored to your specific medical condition or health needs. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

Emergency Situations

If you think you may have a medical emergency, call your doctor or emergency services immediately. In Nepal, call 102 for emergency services or go to the nearest hospital emergency room.

Emergency Contact Information:

National Emergency:

102 (Ambulance)

Our Clinic:

+977-9700682800 (WhatsApp available 24/7)

Bir Hospital Emergency:

+977-1-4412400

TU Teaching Hospital:

+977-1-4434320

Timeliness of Information

Medical information changes rapidly. While we strive to provide current and accurate information, we make no guarantees about the completeness, accuracy, reliability, suitability, or availability with respect to the website or the information contained on the website.

Professional Medical Advice Required

Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you have any specific questions about any medical matter, you should consult your doctor or other professional healthcare provider.

Treatment and Diagnosis

Do not use the information on this website to diagnose or treat any health problem or disease. The descriptions of treatments and medications provided are for general informational purposes only and do not constitute medical advice.

Limitation of Liability

In no event shall we be liable for any loss or damage arising from the use of this website or reliance on the information provided herein. This includes, but is not limited to, direct, indirect, incidental, punitive, and consequential damages.

Nepal-Specific Considerations

This website is operated in Nepal and is intended for users in Nepal. The medical information provided may not be applicable to healthcare systems outside Nepal. Always consult with local healthcare providers familiar with Nepal's healthcare system and regulations.

Last Updated: November 20, 2026 |Clinic: Thamel Clinic |Licensed: Registered

WhatsAppBook Now